-
Innovation Ranking
Innovation Ranking - Pacira BioSciences Inc
Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute postsurgical pain. Its other products include iovera, a non-opioid treatment intended to block pain, and relieve pain and symptoms related to...
-
Innovation Ranking
Innovation Ranking - Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company engaged in the development of sotagliflozin in type 1 diabetes, which was the subject of a separate NDA, in which NDA is in positive results of the third phase clinical trials evaluating the effect of sotagliflozin on type 1 diabetes in approximately 800, 800 and 1,400 patients. The company has advanced multiple drug candidates into clinical...
-
Innovation Ranking
Innovation Ranking - Merrimack Pharmaceuticals Inc
Merrimack Pharmaceuticals Inc (Merrimack) is a clinical-stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. It's first commercial product was Onivyde (irinotecan liposome injection) a liposomal formulation for treating advanced pancreatic cancer patients. Merrimack is entitled to receive milestone payments related to sale of Onivyde and MM-436 to Ipsen SA. Merrimack is headquartered in Cambridge, Massachusetts, the US.
-
Innovation Ranking
Innovation Ranking - BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc (BioMarin) develops and commercializes innovative medicines for the treatment of rare genetic diseases and medical conditions such as Duchenne muscular dystrophy (DMD), achondroplasia, phenylketonuria (PKU), late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. The company focuses on developing breakthrough treatments for debilitating and life-threatening diseases. Its product category consists of multiple clinical and preclinical offerings which include Naglazyme-Mucopolysaccharidosis Type VI (MPS VI), Aldurazyme-MPS I and others. The company operates through its manufacturing facilities in Novato, California....
-
Innovation Ranking
Innovation Ranking - Biotest AG
Biotest AG (Biotest), a subsidiary of Grifols SA, provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products include clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, haematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and...
-
Innovation Ranking
Innovation Ranking - Mirati Therapeutics Inc
Mirati Therapeutics Inc (Mirati Therapeutics) is a clinical-stage oncology company that carries out the research and development of novel therapeutics to address the genetic and immunological promoters of cancer. The company product pipeline includes Adagrasib (MRTX849), an oral small molecule inhibitor of KRASG12C and MRTX1133, a potent small molecule inhibitor of the KRASG12D for the treatment of colorectal and pancreatic cancer. Mirati Therapeutics also offers MRTX1133 - pancreatic cancer and Sitravatinib - Tumor, MRTX1719 -methylthioadenosine phosphorylase (MTAP) deleted cancers and...
-
Innovation Ranking
Innovation Ranking - Diageo Plc
Diageo Plc (Diageo) is a producer, distributor and marketer of spirits and beer products. Its product portfolio includes scotch, beer, brandy, vodka, Indian-made foreign liquor (IMFL), whiskey, rum, ready-to-drink (RTD) alcoholic beverages, liqueur, wine, gin, and tequila. The company markets products under Johnnie Walker, Smirnoff, Baileys, Captain Morgan, Tanqueray, Guinness, McDowell’s No.1 and CIROC brand names. Diageo produces its products through owned and leased manufacturing facilities, distilling, blending, bottling, and packaging facilities. The company distributes products through independent wholesalers, resellers...
-
Innovation Ranking
Innovation Ranking - Lumos Pharma Inc
Lumos Pharma Inc (Lumos Pharma), formerly NewLink Genetics Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of new therapies for the treatment of unmet medical needs of rare diseases. The company’s lead investigating candidate, LUM-201 (ibutamoren) is an oral growth hormone stimulating therapy for the treatment of pediatric growth hormone deficiency (PGHD), turner syndrome, children born small for gestational age (SGA), and other rare endocrine disorders. Lumos Pharma is headquartered in Austin, Texas, the US.
-
Innovation Ranking
Innovation Ranking - Vaxart Inc
Vaxart Inc (Vaxart), formerly Aviragen Therapeutics Inc, is a clinical-stage pharmaceutical company that develops oral recombinant vaccines based on its proprietary oral vaccine platform, using state-of-the-art recombinant technology. The platform enables the company to develop oral versions of currently available vaccines, and design recombinant vaccines for new indications. The company is developing prophylactic vaccine candidates for a range of infectious diseases, including norovirus infection, seasonal influenza, respiratory syncytial virus (RSV) infection, and coronavirus (COVID-19) disease. It is also developing a...
-
Innovation Ranking
Innovation Ranking - Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc (Amphastar), is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal and inhalation products. It sells insulin-active pharmaceutical ingredient products. The company’s key products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; epinephrine, naloxone, phytonadione, primatene mist and glucagon. Amphastar offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.